Progyny Inc [PGNY] stock is trading at $28.95, down -0.24%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The PGNY shares have gain 2.44% over the last week, with a monthly amount glided 1.19%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Progyny Inc [NASDAQ: PGNY] stock has seen the most recent analyst activity on July 16, 2024, when JMP Securities initiated its Mkt Outperform rating and assigned the stock a price target of $36. Previously, KeyBanc Capital Markets downgraded its rating to Sector Weight on May 10, 2024. On February 26, 2024, Leerink Partners initiated with a Outperform rating and assigned a price target of $49 on the stock. Barclays started tracking the stock assigning a Overweight rating and suggested a price target of $48 on January 03, 2024. Canaccord Genuity initiated its recommendation with a Buy and recommended $46 as its price target on September 27, 2023. BTIG Research started tracking with a Buy rating for this stock on May 22, 2023, and assigned it a price target of $50. In a note dated April 21, 2023, Cantor Fitzgerald initiated an Overweight rating and provided a target price of $44 on this stock.
Progyny Inc [PGNY] stock has fluctuated between $23.90 and $44.95 over the past year. Currently, Wall Street analysts expect the stock to reach $38 within the next 12 months. Progyny Inc [NASDAQ: PGNY] shares were valued at $28.95 at the most recent close of the market. An investor can expect a potential return of 31.26% based on the average PGNY price forecast.
Analyzing the PGNY fundamentals
Progyny Inc [NASDAQ:PGNY] reported sales of 1.11B for the trailing twelve months, which represents a growth of 7.62%. Gross Profit Margin for this corporation currently stands at 0.22% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.08, Equity is 0.12 and Total Capital is 0.11. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 28.66 points at the first support level, and at 28.38 for the second support level. However, for the 1st resistance point, the stock is sitting at 29.44, and for the 2nd resistance point, it is at 29.94.
Ratios To Look Out For
For context, Progyny Inc’s Current Ratio is 3.31. In addition, the Quick Ratio stands at 3.31 and the Cash Ratio stands at 0.56. Considering the valuation of this stock, the price to sales ratio is 2.49, the price to book ratio is 4.80 and price to earnings (TTM) ratio is 47.65.
Transactions by insiders
Recent insider trading involved Payson Norman, Director, that happened on Nov 23 ’24 when 200.0 shares were sold. PRESIDENT, Sturmer Michael E completed a deal on Jul 16 ’24 to sell 9030.0 shares. Meanwhile, Director Scott Cheryl sold 1462.0 shares on Jun 28 ’24.
